| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 121.2K | $115.1K | - | |
| ? | 95.2K | $90.4K | - | |
| Dir | 49.5K | $47.0K | - | |
| CFO | 9.5K | $9.0K | - | |
| COO | 9.1K | $8.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | Aaron G.L. Fletcher47 | Director, 10% Owner | Buy | 50,000 | $1.93 | $96,500.00 | +9.9% | -20.2% | -42.4% | |
| Aug 16, 2022 | Leslie W. Kreis45 | Director, 10% Owner | Buy | 1,773,684 | $1.90 | $3,369,999.60 | -143.8% | -19.6% | -37.0% | |
| Aug 16, 2022 | Emily Fairbairn | Director, 10% Owner | Buy | 789,473 | $1.90 | $1,499,998.70 | +23.8% | -19.6% | -37.0% | |
| Aug 16, 2022 | William Tai-Wei Ho | President, CEO and CFO | Buy | 26,315 | $1.90 | $49,998.50 | +1.1% | -19.6% | -37.0% | |
| Aug 16, 2022 | Kate Rochlin | Chief Operating Officer | Buy | 5,263 | $1.90 | $9,999.70 | New | -19.6% | -37.0% | |
| Aug 16, 2022 | Patrick McCall | Chief Financial Officer | Buy | 5,263 | $1.90 | $9,999.70 | New | -19.6% | -37.0% | |
| Aug 16, 2022 | Trishna Goswami | Chief Medical Officer | Buy | 2,631 | $1.90 | $4,998.90 | New | -19.6% | -37.0% | |
| Aug 16, 2022 | Lawrence Lamb | EVP and CSO | Buy | 526 | $1.90 | $999.40 | +0.5% | -19.6% | -37.0% | |
| Aug 16, 2022 | Peter C. Brandt | Director | Buy | 105,263 | $1.90 | $199,999.70 | +136.3% | -19.6% | -37.0% | |
| Aug 16, 2022 | Alan S. Roemer | Director | Buy | 26,315 | $1.90 | $49,998.50 | +88.7% | -19.6% | -37.0% |